Dimensional Fund Advisors LP reduced its position in Paragon 28, Inc. (NYSE:FNA – Free Report) by 49.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 132,738 shares of the company’s stock after selling 129,946 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Paragon 28 were worth $908,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in FNA. PNC Financial Services Group Inc. purchased a new stake in Paragon 28 in the 4th quarter worth about $25,000. Nisa Investment Advisors LLC raised its position in Paragon 28 by 46,660.0% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company’s stock worth $32,000 after purchasing an additional 4,666 shares during the period. Levin Capital Strategies L.P. purchased a new stake in Paragon 28 in the 2nd quarter worth about $68,000. Price T Rowe Associates Inc. MD raised its position in Paragon 28 by 16.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock worth $156,000 after purchasing an additional 1,766 shares during the period. Finally, Capstone Investment Advisors LLC raised its position in Paragon 28 by 9.0% in the 1st quarter. Capstone Investment Advisors LLC now owns 21,800 shares of the company’s stock worth $269,000 after purchasing an additional 1,800 shares during the period. 63.57% of the stock is owned by hedge funds and other institutional investors.
Paragon 28 Stock Performance
Shares of NYSE:FNA opened at $5.72 on Monday. The firm has a market cap of $477.85 million, a PE ratio of -8.29 and a beta of 0.97. The firm’s 50 day simple moving average is $7.16 and its 200-day simple moving average is $7.90. Paragon 28, Inc. has a one year low of $4.84 and a one year high of $14.79. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.70 and a current ratio of 3.57.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the stock. Needham & Company LLC reduced their price objective on shares of Paragon 28 from $14.00 to $11.00 and set a “buy” rating on the stock in a research report on Friday, August 9th. Piper Sandler reaffirmed an “overweight” rating and set a $12.00 target price (down from $15.00) on shares of Paragon 28 in a research report on Friday, August 9th.
Check Out Our Latest Stock Report on FNA
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Articles
- Five stocks we like better than Paragon 28
- How to Use the MarketBeat Excel Dividend Calculator
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- 3 REITs to Buy and Hold for the Long Term
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Overbought Stocks Explained: Should You Trade Them?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Want to see what other hedge funds are holding FNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paragon 28, Inc. (NYSE:FNA – Free Report).
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.